Genmab A/S annual shares outstanding
2013
2014
2015
2016
2017
2018
2019
2025
Genmab A/S Shares Outstanding History (GMAB)
Genmab A/S reported 64.2M shares outstanding at the end of fiscal 2025.
View full Genmab A/S company overviewGenmab A/S annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 64.2M | −836,094 | −1.28% |
| 2019 | 2019-12-31 | 65.1M | 3.6M | +5.82% |
| 2018 | 2018-12-31 | 61.5M | 311,897 | +0.51% |
| 2017 | 2017-12-31 | 61.2M | 835,618 | +1.38% |
| 2016 | 2016-12-31 | 60.4M | 818,793 | +1.38% |
| 2015 | 2015-12-31 | 59.5M | 2.6M | +4.50% |
| 2014 | 2014-12-31 | 57.0M | 5.2M | +10.07% |
| 2013 | 2013-12-31 | 51.8M | — | — |
Genmab A/S quarterly shares outstanding
Q4.13
Q4.14
Q4.15
Q4.16
Q4.17
Q4.18
Q4.19
Q4.25
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 64.2M | 3.9M | +6.44% |
| Q4 2019 | 2019-12-31 | 65.1M | 5.5M | +9.31% |
| Q4 2018 | 2018-12-31 | 61.5M | 4.5M | +7.95% |
| Q4 2017 | 2017-12-31 | 61.2M | 9.4M | +18.22% |
| Q4 2016 | 2016-12-31 | 60.4M | — | — |
| Q4 2015 | 2015-12-31 | 59.5M | — | — |
| Q4 2014 | 2014-12-31 | 57.0M | — | — |
| Q4 2013 | 2013-12-31 | 51.8M | — | — |
Genmab A/S shares outstanding trends
Over the last five reported fiscal years, Genmab A/S's shares outstanding moved from 59.5M to 64.2M, a change of 4.7M. The latest reported quarter, Q4 2025, shows 64.2M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Genmab A/S filings at SEC.gov ↗